SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001262463-13-000786
Filing Date
2013-11-19
Accepted
2013-11-19 16:19:57
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plplq1.htm 10-Q 200183
2 EXHIBIT 31.1 ex311.htm EX-31 8904
3 EXHIBIT 31.2 ex312.htm EX-31 8851
4 EXHIBIT 32.1 ex321.htm EX-32 4888
5 EXHIBIT 32.2 ex322.htm EX-32 4775
  Complete submission text file 0001262463-13-000786.txt   2145285

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE plpl-20130930.xml EX-101.INS 178780
7 XBRL SCHEMA FILE plpl-20130930.xsd EX-101.SCH 27774
8 XBRL CALCULATION FILE plpl-20130930_cal.xml EX-101.CAL 47736
9 XBRL DEFINITION FILE plpl-20130930_def.xml EX-101.DEF 79691
10 XBRL LABEL FILE plpl-20130930_lab.xml EX-101.LAB 193041
11 XBRL PRESENTATION FILE plpl-20130930_pre.xml EX-101.PRE 148137
Mailing Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102
Business Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102 (435) 881-8734
Plandai Biotechnology, Inc. (Filer) CIK: 0001317880 (see all company filings)

IRS No.: 453642179 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-51206 | Film No.: 131230197
SIC: 2834 Pharmaceutical Preparations